Exploiting Zebrafish Xenografts for Testing the in vivo Antitumorigenic Activity of Microcin E492 Against Human Colorectal Cancer Cells

One of the approaches to address cancer treatment is to develop new drugs not only to obtain compounds with less side effects, but also to have a broader set of alternatives to tackle the resistant forms of this pathology. In this regard, growing evidence supports the use of bacteria-derived peptide...

Descripción completa

Detalles Bibliográficos
Autores principales: Varas, Macarena A., Muñoz-Montecinos, Carlos, Kallens, Violeta, Simon, Valeska, Allende, Miguel L., Marcoleta, Andrés E., Lagos, Rosalba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096547/
https://www.ncbi.nlm.nih.gov/pubmed/32265865
http://dx.doi.org/10.3389/fmicb.2020.00405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096547/
https://www.ncbi.nlm.nih.gov/pubmed/32265865
http://dx.doi.org/10.3389/fmicb.2020.00405

Ejemplares similares